Physician profile
James Wade
NPI 1649405341
$128,501.45
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2021: $36K · 2022: $25K · 2023: $29K · 2024: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $52K · Travel and Lodging: $6,375 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Food and Beverage: $4,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $52,020.00 |
| Travel and Lodging | $6,375.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Food and Beverage | $4,244.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $128,072.34 | 2019-2024 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $191.87 | 2022 | |
| Davol INC. | $116.07 | 2023 | Phasix Mesh |
| Conmed Corporation | $45.45 | 2021 | |
| Biontech Se | $29.30 | 2023 | |
| Genmab U.S., INC. | $26.42 | 2024 | Tivdak |
| Csl Behring | $20.00 | 2024 | Kcentra |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.